Detailed Description:
An open two stage non-randomized Phase 1 study with the participation of healthy volunteers. This clinical trial is an open study of safety, tolerability and immunogenicity of the drug “Gam-COVID-Vac Lyo”, lyophilisate for the preparation of a solution for intramuscular administration, with the participation of healthy volunteers.

Summary
Review Date
Reviewed Item
Gam-COVID-Vac Lyo
Product Name
Gam-COVID-Vac Lyo

NBScience

contract research organization

stem cell therapy